Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACE: Autologous FMT for ARB Prevention
NCT03061097Phase 1Completed
- Sponsor
- OpenBiome
- Start
- Jul 2017
- Primary completion
- Dec 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of autologous fecal microbiota transplantation in bacterial colonization (2 arms), sponsored by OpenBiome. Primary endpoint: Number of Participants With Adverse Events (NIH Grade ≥2) at Day 7 After Randomization. Started Jul 2017; status: completed.
02
Drugs
autologous fecal microbiota transplantation
03
Conditions
bacterial colonization
Beyond the preview
Go deeper on NCT03061097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061097.